➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
McKesson
AstraZeneca
Harvard Business School
Colorcon

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Nafcillin sodium - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for nafcillin sodium and what is the scope of patent protection?

Nafcillin sodium is the generic ingredient in five branded drugs marketed by Wyeth Ayerst, Antibiotice, Apothecon, Aurobindo Pharma Ltd, Fresenius, Istituto Bio Ita Spa, Mylan Labs Ltd, Sagent Pharms, Sandoz, Watson Labs Inc, Glaxosmithkline, and Baxter Hlthcare, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for nafcillin sodium. Ten suppliers are listed for this compound.

Recent Clinical Trials for nafcillin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all nafcillin sodium clinical trials

Pharmacology for nafcillin sodium
Medical Subject Heading (MeSH) Categories for nafcillin sodium

US Patents and Regulatory Information for nafcillin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 090580-001 Aug 24, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst UNIPEN nafcillin sodium INJECTABLE;INJECTION 050320-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Istituto Bio Ita Spa NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 090005-001 Apr 20, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
Apothecon NAFCILLIN SODIUM nafcillin sodium INJECTABLE;INJECTION 061984-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst UNIPEN nafcillin sodium INJECTABLE;INJECTION 050320-005 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Baxter
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.